How a group of biotechs ran a covert campaign to push out the FDA commissionernews2026-05-21T18:26:01+00:00May 21st, 2026|Endpoints News|
China’s drugmakers to take the stage at #ASCO26news2026-05-21T15:39:53+00:00May 21st, 2026|Endpoints News|
BioMarin to seek further approval of Voxzogo in form of short staturenews2026-05-21T14:31:00+00:00May 21st, 2026|Endpoints News|
Incyte signs AI deals with Genesis Molecular AI, Edison Scientificnews2026-05-21T14:22:03+00:00May 21st, 2026|Endpoints News|
BMS eyes new campus in Texas; Novartis looks to evict tenant at Slovenian campusnews2026-05-21T13:02:14+00:00May 21st, 2026|Endpoints News|
Lilly’s triple agonist still leads among late-stage obesity assetsnews2026-05-21T10:45:31+00:00May 21st, 2026|Endpoints News|
I&I biotech cAMPfield attracts top-tier investors in $180M Series Anews2026-05-20T18:12:37+00:00May 20th, 2026|Endpoints News|
The next big pharma company will come from Chinanews2026-05-20T17:44:24+00:00May 20th, 2026|Endpoints News|
Driven by GLP-1s, pharma’s relationship with consumers is starting to changenews2026-05-20T17:26:36+00:00May 20th, 2026|Endpoints News|
Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175Mnews2026-05-20T15:04:35+00:00May 20th, 2026|Endpoints News|
